minocycline HCl 2.1%
DrugMinocycline HCl 2.1% gel as an adjunct to scaling and root planing. Dosing is by topical delivery into gingival pockets at baseline, 2 weeks, 4 weeks, 3 months and 6 months.
Other names: periocline
NCT Number: NCT00529555
Periodontal disease (commonly called gum disease) is generally treated by deep cleaning of the root surfaces of the teeth. This is also called scaling and root planing. Placing a topical antibiotic into the periodontal pocket at the time of scaling and root planing may help reduce pocket depth and thus help the periodontal disease. Periocline (minocycline HCl) 2.1% gel is a topical antibiotic approved in a number of countries for this use, and is now being tested in the US.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
University of Alabama at Birmingham, Birmingham, Alabama, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Minocycline HCl 2.1% gel as an adjunct to scaling and root planing. Dosing is by topical delivery into gingival pockets at baseline, 2 weeks, 4 weeks, 3 months and 6 months.
Other names: periocline
scaling and root planing
Other names: SRP
Time frame: baseline & 9 months
Average change of Pocket Depth at 9 months from baseline
Sunstar Americas
Industry
A 9 Month,3-arm Multicenter Clinical Trial of Treatment With Periocline Gel (2.1% Minocycline HCl) for Adjunctive Use to Scaling and Root Planing (SRP) in Adults With Periodontal Disease.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04493398
Adult Periodontitis, Chronic Disease
View Trial DetailsNCT03677297
Adult Periodontitis, Chronic Disease
Pune, Maharashtra, India
View Trial DetailsNCT00221130
Adult Periodontitis, Chronic Disease
Kobe, Hyogo Pref., Japan
View Trial DetailsNCT06893107
Chronic Disease, Chronic Periodontitis
Fujairah, Emirate of Fujairah, United Arab Emirates
View Trial Details